• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    TC BioPharm (Holdings) plc - American Depositary Shares (NQ: TCBP )

    1.340 +0.030 (+2.29%)
    Streaming Delayed Price Updated: 11:00 AM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about TC BioPharm (Holdings) plc - American Depositary Shares

    InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Updates Shareholders on Major Milestones, Expands Clinical Trial Sites and Secures $8M Funding in 2024
    Via Investor Brand Network
    BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Collaboration for Monkeypox Treatment Development
    Via Investor Brand Network
    BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP), Carnegie Mellon University Partner to Potentially Revolutionize Donor Selection, Matching Processes with AI
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Newly Opened London-Based ACHIEVE UK Trial Site Amid ‘Very Positive’ Study Progression
    Via Investor Brand Network
    BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Featured at Next Month’s NYC ThinkEquity Conference
    Via Investor Brand Network
    BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Completes ACHIEVE Trial Full-Dose Regimen for First Patient
    Via Investor Brand Network
    InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Marks Milestone as First Patient Completes Full Dose in ACHIEVE Trial with No Adverse Events
    Via Investor Brand Network
    BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Plans Preclinical Studies for Treatment of Monkey Pox
    Via Investor Brand Network
    BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) CEO to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Via Investor Brand Network
    BioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Doses Five New Patients in UK ACHIEVE Phase 2b Trial
    Via Investor Brand Network
    TC BioPharm CEO, Bryan Kobel, is Featured on The Stock Day Podcast
    Phoenix, Arizona--(Newsfile Corp. - July 6, 2023) - The Stock Day Podcast welcomed TC BioPharm Holdings, PLC. (NASDAQ: TCBP) ("the... 
    Via Newsfile
    Exposures Product Safety
    Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
    EQNX::TICKER_START (NASDAQ:TCBP),(NASDAQ:CRDF),(NASDAQ:CYAD),(NASDAQ:RIGL),(NASDAQ:AZN) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Exposures COVID-19 Product Safety
    Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
    EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Exposures Product Safety
    TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
    EQNX::TICKER_START (NASDAQ:TCBP) EQNX::TICKER_END 
    Via FinancialNewsMedia
    TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune
    Via AB Newswire
    Topics Death Economy Stocks
    Exposures COVID-19 Death Interest Rates
    InvestorNewsBreaks – TC Biopharm PLC (NASDAQ: TCBP) Closes on $17.5M Public Offering
    Via Investor Brand Network
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.